[1] |
CHOWDHURY AB, MEHTA KJ. Liver biopsy for assessment of chronic liver diseases: A synopsis[J]. Clin Exp Med, 2023, 23( 2): 273- 285. DOI: 10.1007/s10238-022-00799-z.
|
[2] |
KUBES P, JENNE C. Immune responses in the liver[J]. Annu Rev Immunol, 2018, 36: 247- 277. DOI: 10.1146/annurev-immunol-051116-052415.
|
[3] |
COVELLI C, SACCHI D, SARCOGNATO S, et al. Pathology of autoimmune hepatitis[J]. Pathologica, 2021, 113( 3): 185- 193. DOI: 10.32074/1591-951X-241.
|
[4] |
LOHSE AW, SEBODE M, BHATHAL PS, et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology[J]. Liver Int, 2022, 42( 5): 1058- 1069. DOI: 10.1111/liv.15217.
|
[5] |
ZHANG X, JAIN D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis[J]. Hum Pathol, 2023, 132: 114- 125. DOI: 10.1016/j.humpath.2022.06.019.
|
[6] |
LIU ZR, ZHU Y, XIE H, et al. Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives[J]. Front Pharmacol, 2023, 13: 1077468. DOI: 10.3389/fphar.2022.1077468.
|
[7] |
MURATORI L, LOHSE AW, LENZI M. Diagnosis and management of autoimmune hepatitis[J]. BMJ, 2023, 380: e070201. DOI: 10.1136/bmj-2022-070201.
|
[8] |
ZEN Y. Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis[J]. Semin Diagn Pathol, 2024, 41( 2): 79- 87. DOI: 10.1053/j.semdp.2024.01.001.
|
[9] |
GUPTA R, NEYAZ A, CHOUGULE A, et al. Autoimmune pancreatitis type 2: Diagnostic utility of PD-L1 immunohistochemistry[J]. Am J Surg Pathol, 2019, 43( 7): 898- 906. DOI: 10.1097/PAS.0000000000001282.
|
[10] |
KU YN, HONG SM, FUJIKURA K, et al. IL-8 expression in granulocytic epithelial lesions of idiopathic duct-centric pancreatitis(type 2 autoimmune pancreatitis)[J]. Am J Surg Pathol, 2017, 41( 8): 1129- 1138. DOI: 10.1097/PAS.0000000000000891.
|
[11] |
SAYED AHMED A, ABREO M, THOMAS A, et al. Type 3 autoimmune pancreatitis(immune checkpoint inhibitor-induced pancreatitis)[J]. Curr Opin Gastroenterol, 2022, 38( 5): 516- 520. DOI: 10.1097/MOG.0000000000000873.
|